Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: 2010 = increasing shareholder value.

It'd be nice to see PTSC on a bigger board but they wouldn't last long. They don't have a steady revenue.

They go through ceo's like tic tacs and they don't talk to their shareholds. That doesn't help.

Share
New Message
Please login to post a reply